Danaher Corporation Stock News

HTHIY vs. DHR: Which Stock Is the Better Value Option?

The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

The fourth quarter earnings season is always the most important because it reveals the full year performance of the companies as well.

High raw material costs and supply-chain disruptions are likely to have hurt Danaher's (DHR) Q4 earnings. However, the top line is likely to have benefited from an expected increase in revenues at the

Ron Baron (Trades, Portfolio) and Daniel Loeb (Trades, Portfolio) are two gurus that follow very different investing styles. While both focus on the long term, Baron's Baron Funds aims to invest in va

As requested by many, I decided to dedicate an article to my personal dividend growth portfolio, consisting of more than 90% of my net worth. I start by explaining my strategy and approach, followed b

In this article, I revisit the life sciences "picks and shovels" market leaders Danaher Corporation and Thermo Fisher Scientific Inc. I will review changes since the initial comparative piece two quar

Danaher Corporation (NYSE:DHR ) 41st Annual J.P. Morgan Healthcare Conference Call January 10, 2023 4:30 PM ET Company Participants Rainer Blair - President and Chief Executive Officer Conference Call

Benefiting from strong growth in Cepheid's molecular diagnostics among other factors, Danaher (DHR) improves its adjusted core revenue growth guidance for the fourth quarter of 2022.

Danaher Corp. DHR, +1.01% on Monday said it expected fourth-quarter sales to rise in the “low-single-digit percent range,” despite what executives said was a “challenging environment” for the

WASHINGTON , Jan. 3, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

The "Halftime Report" traders give their top picks to watch for the second half.